Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density

Cristina Pintado1, Elisa Revilla, María L Vizuete

  • 1Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, Spain.

Insights

Microglial cell density influences immune responses. Higher densities enhance pro-inflammatory factors like TNF-α and iNOS, while decreasing anti-inflammatory IL-10, impacting neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells of the central nervous system.
  • Microglial activation plays a critical role in neuroinflammation and neurodegenerative diseases.
  • The impact of microglial cell density on activation states remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between N13 microglial cell density and their activation state.
  • To determine how cell density affects the release of pro-inflammatory and anti-inflammatory mediators.
  • To correlate in vitro findings with in vivo observations in specific brain regions.

Main Methods:

  • In vitro assays using N13 microglia at three different densities stimulated with lipopolysaccharide (LPS).
  • Quantification of pro-inflammatory factors (TNF-α, iNOS) and anti-inflammatory factor (IL-10) expression.
  • In vivo LPS-injection model in mice to assess iNOS and IL-10 expression in substantia nigra and striatum.

Main Results:

  • In vitro: Pro-inflammatory factor induction (TNF-α, iNOS) was directly proportional to cell density.
  • In vitro: Anti-inflammatory factor induction (IL-10) was inversely proportional to cell density.
  • In vivo: iNOS expression was higher in the susceptible substantia nigra, while IL-10 was more sustained in the resistant striatum.

Conclusions:

  • Microglial cell density is a critical factor modulating the balance of pro- and anti-inflammatory responses.
  • Cell density influences the differential expression of inflammatory mediators in specific brain regions.
  • Understanding density-dependent microglial activation is crucial for developing targeted neuroinflammatory therapies.

Related Concept Videos